Optical resolution of narwedine-type compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6346618
SERIAL NO

09194332

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A process for the asymmetric transformation of a racemic compound of formula (I) wherein R.sub.1 is H or a alkyl group having up to 20 carbon atoms, R.sub.2 is H, or an alkyl, aryl, alkaryl or aralkyl group having up to 20 carbon atoms, and X is H, a halogen atom, tert-butyl, or any other removable substituent, comprises reaction of racemic compound (I) with an enantiomerically-enriched acid HY*, wherein Y* is a chiral group, to form a diastereomeric salt of compound (I) having Y* as a counterion. The salt obtained can then be reduced to give enantiomerically-enriched galanthamine, or a derivative thereof. ##STR1##

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JANSSEN PHARMACEUTICA N VBEERSE BEERSE ANTWERP

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chaplin, David Andrew Cambridge, GB 3 2
Johnson, Nicholas Bernard Cambridge, GB 8 10
Paul, Jane Marie Cambridge, GB 5 6
Potter, Gerard Andrew Cambridge, GB 15 29

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation